Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2025 pubmed 3 citations

The Potential Effect of Endogenous Antimicrobial Peptides in Cancer Immunotherapy and Prevention.

Tran. Tuan Hiep TH; Le. Thanh Huong TH; Tran. Thi Thu Phuong TTP

Key Findings

  • Antimicrobial peptides (AMPs) such as LL‑37 have anti‑cancer properties in addition to fighting microbes.
  • AMPs can modulate the immune system and may improve the selectivity of cancer treatments.
  • Their natural abundance and safety profile make them attractive candidates for future cancer immunotherapies.

Practical Outcomes

  • For now, there’s no actionable supplement or protocol for biohackers. The main takeaway is that LL‑37 and similar peptides are being studied as potential cancer‑fighting agents, so keep an eye on emerging clinical trials for any future dosage guidelines.

Summary

This review talks about natural proteins like LL‑37 that our bodies make to fight germs. Besides killing microbes, these proteins can also help kill cancer cells, heal wounds, and tweak the immune system. Because they’re already in our bodies and seem safe, scientists think they could become new tools for cancer prevention or therapy, but the paper doesn’t give any specific dosing or how to use them now.

Abstract

Antimicrobial peptides (AMPs) are crucial constituents of inherent immunity and serve as vital components of human host defense, playing a pivotal role in combating invading microbial pathogens. Beyond their antimicrobial functions, AMPs also exhibit various other biological activities including apoptosis induction, wound healing promotion, and immune modulation. These peptides are found in various exposed tissues or surfaces throughout the body, such as eyes, skin, mouth, ears, respiratory tract, lungs, digestive, and urinary system. Additionally, certain AMPs such as LL-37, HNP, and lactoferrin have shown potential as candidates for anticancer activity. Given the limited selectivity between normal and cancer cells exhibited by many current immunotherapeutic agents, the inherent properties of AMPs make them promising candidates for cancer treatment. Their abundance, bioavailability, safety profile, efficiency, and harmony with the host immune system position them as attractive tools in the fight against cancer. This review is aimed at exploring the potential anticancer properties of AMPs and elucidating their relationship with immunology and cancer immunotherapy.

Study Information

Provider

pubmed

Year

2025

Date

2024-12-23T00:00:00.000Z

DOI

10.1002/psc.3664

Citations

3

References

127